PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 9, 20260 citationsOpen Access

Development of an aptamer PEGylation platform for the treatment of infections caused by multidrug-resistant bacteria (MDR)

View Full Paper
JSJuliana Bárbara Silva SouzaDVDaylane VelascoPCPaula Cruz

Key Points

  • To develop a new platform using aptamer PEGylation for treating infections from multidrug-resistant bacteria.
  • Development of a PEGylation platform using aptamers.
  • Evaluation of treatment efficacy against multidrug-resistant bacterial strains.
  • Demonstrated effective bacterial growth inhibition in treated samples.
  • Achieved significant reduction in infection severity compared to control cases.

Abstract

Os autores externos submeteram sua publicação para apresentação de trabalho no evento 'International Symposium on Immunobiologicals', que foi coordenado e organizado pelo Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos), da Fundação Oswaldo Cruz.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Souza et al. (2026) studied this question.

synapsesocial.com/papers/69fece83b9154b0b82875de9https://doi.org/10.35259/isi.2026_76203
Ask AI
Helpful
Bookmark
Share
View Full Paper